140 related articles for article (PubMed ID: 14502475)
1. On the physical interpretation of QSAR models.
Stanton DT
J Chem Inf Comput Sci; 2003; 43(5):1423-33. PubMed ID: 14502475
[TBL] [Abstract][Full Text] [Related]
2. A three-dimensional quantitative structure-activity analysis of a new class of bisphenol topoisomerase IIalpha inhibitors.
Liang H; Wu X; Yalowich JC; Hasinoff BB
Mol Pharmacol; 2008 Mar; 73(3):686-96. PubMed ID: 18045852
[TBL] [Abstract][Full Text] [Related]
3. Understanding topoisomerase I and II in terms of QSAR.
Verma RP
Bioorg Med Chem; 2005 Feb; 13(4):1059-67. PubMed ID: 15670914
[TBL] [Abstract][Full Text] [Related]
4. QSAR studies about cytotoxicity of benzophenazines with dual inhibition toward both topoisomerases I and II: 3D-MoRSE descriptors and statistical considerations about variable selection.
Saíz-Urra L; González MP; Teijeira M
Bioorg Med Chem; 2006 Nov; 14(21):7347-58. PubMed ID: 16962784
[TBL] [Abstract][Full Text] [Related]
5. The interaction of drugs with DNA gyrase: a model for the molecular basis of quinolone action.
Heddle JG; Barnard FM; Wentzell LM; Maxwell A
Nucleosides Nucleotides Nucleic Acids; 2000 Aug; 19(8):1249-64. PubMed ID: 11097055
[TBL] [Abstract][Full Text] [Related]
6. Improvement of multivariate image analysis applied to quantitative structure-activity relationship (QSAR) analysis by using wavelet-principal component analysis ranking variable selection and least-squares support vector machine regression: QSAR study of checkpoint kinase WEE1 inhibitors.
Cormanich RA; Goodarzi M; Freitas MP
Chem Biol Drug Des; 2009 Feb; 73(2):244-52. PubMed ID: 19207427
[TBL] [Abstract][Full Text] [Related]
7. Optimized block-wise variable combination by particle swarm optimization for partial least squares modeling in quantitative structure-activity relationship studies.
Lin WQ; Jiang JH; Shen Q; Shen GL; Yu RQ
J Chem Inf Model; 2005; 45(2):486-93. PubMed ID: 15807514
[TBL] [Abstract][Full Text] [Related]
8. QSAR study of PETT derivatives as potent HIV-1 reverse transcriptase inhibitors.
Sabet R; Fassihi A; Moeinifard B
J Mol Graph Model; 2009 Sep; 28(2):146-55. PubMed ID: 19570701
[TBL] [Abstract][Full Text] [Related]
9. 3D-QSAR analysis on benzazole derivatives as eukaryotic topoisomerase II inhibitors by using comparative molecular field analysis method.
Temiz-Arpaci O; Tekiner-Gulbas B; Yildiz I; Aki-Sener E; Yalcin I
Bioorg Med Chem; 2005 Dec; 13(23):6354-9. PubMed ID: 15993083
[TBL] [Abstract][Full Text] [Related]
10. A novel 3D-QSAR comparative molecular field analysis (CoMFA) model of imidazole and quinazolinone functionalized p38 MAP kinase inhibitors.
Sperandio da Silva GM; Sant'Anna CM; Barreiro EJ
Bioorg Med Chem; 2004 Jun; 12(12):3159-66. PubMed ID: 15158784
[TBL] [Abstract][Full Text] [Related]
11. Quantitative structure activity relationship (QSAR) of piperine analogs for bacterial NorA efflux pump inhibitors.
Nargotra A; Sharma S; Koul JL; Sangwan PL; Khan IA; Kumar A; Taneja SC; Koul S
Eur J Med Chem; 2009 Oct; 44(10):4128-35. PubMed ID: 19523722
[TBL] [Abstract][Full Text] [Related]
12. Structure-based approach to pharmacophore identification, in silico screening, and three-dimensional quantitative structure-activity relationship studies for inhibitors of Trypanosoma cruzi dihydrofolate reductase function.
Schormann N; Senkovich O; Walker K; Wright DL; Anderson AC; Rosowsky A; Ananthan S; Shinkre B; Velu S; Chattopadhyay D
Proteins; 2008 Dec; 73(4):889-901. PubMed ID: 18536013
[TBL] [Abstract][Full Text] [Related]
13. Dual-targeting properties of the 3-aminopyrrolidyl quinolones, DC-159a and sitafloxacin, against DNA gyrase and topoisomerase IV: contribution to reducing in vitro emergence of quinolone-resistant Streptococcus pneumoniae.
Okumura R; Hirata T; Onodera Y; Hoshino K; Otani T; Yamamoto T
J Antimicrob Chemother; 2008 Jul; 62(1):98-104. PubMed ID: 18390884
[TBL] [Abstract][Full Text] [Related]
14. A high dimensional QSAR study on the aldose reductase inhibitory activity of some flavones: topological descriptors in modeling the activity.
Prabhakar YS; Gupta MK; Roy N; Venkateswarlu Y
J Chem Inf Model; 2006; 46(1):86-92. PubMed ID: 16426043
[TBL] [Abstract][Full Text] [Related]
15. Quantitative structure-activity relationship (QSAR) studies of quinolone antibacterials against M. fortuitum and M. smegmatis using theoretical molecular descriptors.
Bagchi MC; Mills D; Basak SC
J Mol Model; 2007 Jan; 13(1):111-20. PubMed ID: 16932890
[TBL] [Abstract][Full Text] [Related]
16. Exploring QSAR for substituted 2-sulfonyl-phenyl-indol derivatives as potent and selective COX-2 inhibitors using different chemometrics tools.
Khoshneviszadeh M; Edraki N; Miri R; Hemmateenejad B
Chem Biol Drug Des; 2008 Dec; 72(6):564-74. PubMed ID: 19090923
[TBL] [Abstract][Full Text] [Related]
17. Quantitative structure-activity relationship studies on 2-amino-6-arylsulfonylbenzonitriles as human immunodeficiency viruses type 1 reverse transcriptase inhibitors using descriptors obtained from substituents and whole molecular structures.
Hemmateenejad B; Sabet R; Fassihi A
Chem Biol Drug Des; 2009 Oct; 74(4):405-15. PubMed ID: 19691465
[TBL] [Abstract][Full Text] [Related]
18. QSAR analysis of substituted bis[(acridine-4-carboxamide)propyl]methylamines using optimized block-wise variable combination by particle swarm optimization for partial least squares modeling.
Lin L; Lin WQ; Jiang JH; Shen GL; Yu RQ
Eur J Pharm Sci; 2005 Jun; 25(2-3):245-54. PubMed ID: 15911220
[TBL] [Abstract][Full Text] [Related]
19. Streptococcus pneumononiae gyrase ATPase: development and validation of an assay for inhibitor discovery and characterization.
Miller JR; Herberg JT; Tomilo M; McCroskey MC; Feilmeier BJ
Anal Biochem; 2007 Jun; 365(1):132-43. PubMed ID: 17395144
[TBL] [Abstract][Full Text] [Related]
20. Predictive QSAR modeling of HIV reverse transcriptase inhibitor TIBO derivatives.
Mandal AS; Roy K
Eur J Med Chem; 2009 Apr; 44(4):1509-24. PubMed ID: 18760864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]